Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice.
An LNP is reported that efficiently delivers reporter mRNA to human HSPCs both in ex vivo and in vivo settings when conjugated with the anti-CD34 antibody (CD34/LNPDP).